GlassScriptPhysician profile
Ashley A Mcclain
NPI 1659669760
$5,387.41
in general payments reported to CMS, 2019-2025
23 companies · $463 in 2025
The $463 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,822 · 2020: $855 · 2021: $503 · 2022: $638 · 2023: $921 · 2024: $186 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,398 · Long Term Medical Supply Or Device Loan: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,398.34 |
| Long Term Medical Supply Or Device Loan | $170.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,299.46 | 2019-2025 | Prophecy, Ortholoc 2 Lapifuse, Axs Infinity Ls |
| Medical Device Business Services, INC. | $1,228.90 | 2019 | |
| Wardlow Enterprises | $567.43 | 2020 | |
| Smith+Nephew, INC. | $428.85 | 2019-2025 | Renasys Go V2 Home, Pico 7, Collagenase Santyl |
| Depuy Synthes Sales INC. | $410.49 | 2019-2022 | |
| Abbvie INC. | $310.30 | 2021-2024 | |
| Integra Lifesciences Corporation | $271.69 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $173.40 | 2021-2022 | |
| Organogenesis INC. | $121.47 | 2022-2025 | Affinity, Puraply, Puraply Wound Matrix |
| Heron Therapeutics, INC. | $120.88 | 2021-2024 | Zynrelef |
| Zimmer Biomet Holdings, INC. | $97.43 | 2021 | |
| Medline Industries LP | $87.62 | 2023 | |
| Kerecis Limited | $40.34 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Tactile Systems Technology INC | $36.11 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Misonix INC | $35.64 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $35.14 | 2022-2024 | Urgoclean Ag |
| Vertex Pharmaceuticals Incorporated | $25.72 | 2025 | |
| Ossio INC | $22.77 | 2023 | |
| Novo Nordisk INC | $19.20 | 2019 | |
| Solventum Corporation | $15.72 | 2025 | Activ.A.C. |
| Boston Scientific Corporation | $15.07 | 2022 | |
| Abbott Laboratories | $11.92 | 2019 | |
| Arthrex, INC. | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Mcclain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.